Posted in | News | Chemical Sensor

Pronghorn Total Residual Oxidant Sensor for Shipboard Desalination Systems

An amount of $300,000 has been received by Pronghorn Technologies as Phase II Enhancement funding relating to its total residual oxidant (TRO) sensor’s further development. The NAVSEA and the U.S. Department of Defense has pooled in $150,000 each.

Pronghorn Technologies

The work will be performed by Pronghorn at its Laramie, Wyoming-based Technology Business Center. The TRO sensor, undergoing development since 2005, can be utilized with enhanced shipboard desalination systems. The in-stream and compact sensor can continuously detect and report residual oxidant levels present in hypochlorite-enhanced seawater streams for killing marine organisms.

Existing new generation sensors have many problems like the inability to offer real-time measurements in real time, inaccuracy caused by calibration issues, fragile construction, and labor-intensive maintenance.

Weston Welch, CFO/COO at Pronghorn Technologies, informed that the one year program on Phase II Enhancement offers the requisite funding for total development of the TRO sensor that will be validated on the shipboard by the US Navy. He explained that the Pronghorn sensor would be able to automate water disinfection systems, thereby prolonging the life of costly equipment and eliminating time-consuming maintenance and safeguarding marine ecosystems from extreme chlorine discharge.

Since 2005, ADA Technologies and Pronghorn Technologies have received about $1.5 million as grant funds for the R & D of the total residual oxidant sensor.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.